Skip to main content
. 2016 Sep 10;37(11):14585–14594. doi: 10.1007/s13277-016-5332-3

Fig. 3.

Fig. 3

Kaplan–Meier survival analyses and log-rank test. a Disease-free survival (DFS) and overall survival (OS) of 117 patients correlated with LARP1 expression were determined by immunohistochemical staining of tissue microarrays. b DFS and OS were significantly higher in patients with PCNA-negative than in PCNA-positive tumors (P < 0.05). c DFS and OS were significantly lower in patients with tumors expressing high rather than low levels of both LARP1 and PCNA (P < 0.01)